| RS2153502277 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153502348 |
COL3A1
|
Health Risk |
Pathogenic |
— |
| RS2153502383 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153502405 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153502406 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153502433 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153502437 |
COL3A1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2153502447 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153502448 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153502552 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153502611 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153502685 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153502692 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS2153502803 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153502988 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153502995 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503006 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503009 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503019 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, Ehlers-Danlos syndrome |
| RS2153503061 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503066 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503227 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503300 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503368 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503377 |
COL3A1
|
Health Risk |
Likely pathogenic |
— |
| RS2153503381 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503430 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503462 |
COL3A1
|
Health Risk |
Likely pathogenic |
— |
| RS2153503495 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503498 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503630 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503632 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503634 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503790 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503888 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503895 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503896 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503949 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503975 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153503988 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS2153504069 |
COL3A1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS2153504329 |
COL3A1
|
Health Risk |
Pathogenic |
— |
| RS2153504449 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153506167 |
COL5A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2153507285 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS2153515061 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153515167 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153515796 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153521056 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS2153536214 |
DDC
|
Health Risk |
Pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS2153537904 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2153545926 |
DDC
|
Health Risk |
Pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS2153550461 |
DDC
|
Health Risk |
Pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS2153552671 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2153553617 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS2153553633 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153554020 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS2153556225 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2153561495 |
GPHN
|
Health Risk |
Pathogenic/Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2153572497 |
CACNA1C
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, language delay |
| RS2153573358 |
ANK2
|
Health Risk |
Likely pathogenic |
— |
| RS2153574675 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153574857 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153585533 |
BRCA1
|
Health Risk |
Pathogenic |
Malignant tumor of breast, Malignant tumor of breast |
| RS2153615795 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153615926 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153617573 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy |
| RS2153617810 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153619687 |
SYNE1
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS2153628887 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS2153647595 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153647734 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, NEB-related disorder |
| RS2153648002 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153655212 |
CACNA1C
|
Health Risk |
Likely pathogenic |
Hypotonia, Hypotonia |
| RS2153655235 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS2153657682 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2153659861 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153668269 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2153668310 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2153685300 |
GPHN
|
Health Risk |
Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2153692395 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic ataxia, Emery-Dreifuss muscular dystrophy 5 |
| RS2153700128 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2153700736 |
BRCA1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2153702280 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS2153702473 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Nemaline myopathy |
| RS2153703181 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153707696 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2153709458 |
SYNE1
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS2153709491 |
CACNA1C
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, CACNA1C-related disorder |
| RS2153711477 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153712099 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153712182 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153713163 |
CACNA1C
|
Health Risk |
Pathogenic |
— |
| RS2153715439 |
SYNE2
|
Health Risk |
Pathogenic |
Cerebral palsy, Cerebral palsy |
| RS2153717733 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2153725036 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2153729614 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153729960 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153732048 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2153739049 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |